Loading clinical trials...

Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects | Clinical Trials | Clareo Health

COMPLETEDPhase 4NCT01229423

Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects

This study will evaluate the safety and efficacy of LATISSE® (bimatoprost 0.03%) in the augmentation of eyelashes in Korean women.

Lead sponsor: Allergan•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 4

Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children

NCT01023841 · Eyelash Hypotrichosis, Alopecia Areata

COMPLETEDPhase 2

Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence

NCT01064882 · Eyelash Hypotrichosis

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 29, 2019Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment62

Start dateNov 2009

Last updatedJan 29, 2019

Condition

Eyelash Hypotrichosis

Locations shown

Seoul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 29, 2019Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions